[HTML] sciencedirect.com

[HTML][HTML] GRP78 inhibitor HA15 increases the effect of Bortezomib on eradicating multiple myeloma cells through triggering endoplasmic reticulum stress

Y Chen, Y Tao, K Hu, J Lu - Heliyon, 2023 - Elsevier
Bortezomib (BTZ), a selective proteasome inhibitor, exhibits a significant efficacy in the
therapy of multiple myeloma (MM) partly through triggering endoplasmic reticulum (ER) …
被引用次数：2 相关文章
[HTML] cell.com

[HTML][HTML] GRP78 inhibitor HA15 increases the effect of Bortezomib on eradicating multiple myeloma cells through triggering endoplasmic reticulum stress

Y Chen, Y Tao, K Hu, J Lu - Heliyon, 2023 - cell.com
Bortezomib (BTZ), a selective proteasome inhibitor, exhibits a significant efficacy in the
therapy of multiple myeloma (MM) partly through triggering endoplasmic reticulum (ER) …

GRP78 inhibitor HA15 increases the effect of Bortezomib on eradicating multiple myeloma cells through triggering endoplasmic reticulum stress.

Y Chen, Y Tao, K Hu, J Lu - Heliyon, 2023 - europepmc.org
Bortezomib (BTZ), a selective proteasome inhibitor, exhibits a significant efficacy in the
therapy of multiple myeloma (MM) partly through triggering endoplasmic reticulum (ER) …

GRP78 inhibitor HA15 increases the effect of Bortezomib on eradicating multiple myeloma cells through triggering endoplasmic reticulum stress

Y Chen, Y Tao, K Hu, J Lu - Heliyon, 2023 - pubmed.ncbi.nlm.nih.gov
Bortezomib (BTZ), a selective proteasome inhibitor, exhibits a significant efficacy in the
therapy of multiple myeloma (MM) partly through triggering endoplasmic reticulum (ER) …

GRP78 inhibitor HA15 increases the effect of Bortezomib on eradicating multiple myeloma cells through triggering endoplasmic reticulum stress

Y Chen, Y Tao, K Hu, J Lu - Heliyon, 2023 - ui.adsabs.harvard.edu
Bortezomib (BTZ), a selective proteasome inhibitor, exhibits a significant efficacy in the
therapy of multiple myeloma (MM) partly through triggering endoplasmic reticulum (ER) …
[HTML] nih.gov

[HTML][HTML] GRP78 inhibitor HA15 increases the effect of Bortezomib on eradicating multiple myeloma cells through triggering endoplasmic reticulum stress

Y Chen, Y Tao, K Hu, J Lu - Heliyon, 2023 - ncbi.nlm.nih.gov
Bortezomib (BTZ), a selective proteasome inhibitor, exhibits a significant efficacy in the
therapy of multiple myeloma (MM) partly through triggering endoplasmic reticulum (ER) …

GRP78 inhibitor HA15 increases the effect of Bortezomib on eradicating multiple myeloma cells through triggering endoplasmic reticulum stress

Y Chen, Y Tao, K Hu, J Lu - europepmc.org
Bortezomib (BTZ), a selective proteasome inhibitor, exhibits a significant efficacy in the
therapy of multiple myeloma (MM) partly through triggering endoplasmic reticulum (ER) …